183 related articles for article (PubMed ID: 21304961)
1. Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.
Liu X; Lin Z; Zhou T; Zong R; He H; Liu Z; Ma JX; Liu Z; Zhou Y
PLoS One; 2011 Jan; 6(1):e16712. PubMed ID: 21304961
[TBL] [Abstract][Full Text] [Related]
2.
Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.
Qiu F; Shin Y; Chen D; Cheng R; Chen Q; Zhou K; Larrick JW; Mendelson AR; Ma JX
Microvasc Res; 2018 Sep; 119():29-37. PubMed ID: 29630973
[TBL] [Abstract][Full Text] [Related]
5. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
6. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
Matsui T; Nishino Y; Maeda S; Yamagishi S
Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
[TBL] [Abstract][Full Text] [Related]
7. SERPINA3K Ameliorates the Corneal Oxidative Injury Induced by 4-Hydroxynonenal.
Zheng X; Cui H; Yin Y; Zhang Y; Zong R; Bao X; Ma JX; Liu Z; Zhou Y
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2874-2883. PubMed ID: 28586911
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.
Li X; Zhou Q; Hanus J; Anderson C; Zhang H; Dellinger M; Brekken R; Wang S
Mol Pharm; 2013 Jan; 10(1):307-18. PubMed ID: 23186311
[TBL] [Abstract][Full Text] [Related]
9. KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.
Zhou AY; Bai YJ; Zhao M; Yu WZ; Li XX
Ophthalmic Res; 2013; 50(3):180-6. PubMed ID: 24008241
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
Lu Y; Zheng Y; Ai J; Xu X
Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina.
Zhang B; Hu Y; Ma JX
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats.
Han Y; Shao Y; Liu T; Qu YL; Li W; Liu Z
PLoS One; 2015; 10(4):e0122951. PubMed ID: 25853509
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
14. The role of pirfenidone in alkali burn rat cornea.
Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
[TBL] [Abstract][Full Text] [Related]
15. The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor.
Chen L; Zhong J; Li S; Li W; Wang B; Deng Y; Yuan J
Drug Des Devel Ther; 2018; 12():2959-2969. PubMed ID: 30254425
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of polysaccharide extract from Spirulina platensis on corneal neovascularization.
Yang L; Wang Y; Zhou Q; Chen P; Wang Y; Wang Y; Liu T; Xie L
Mol Vis; 2009 Sep; 15():1951-61. PubMed ID: 19784394
[TBL] [Abstract][Full Text] [Related]
17. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.
Mirabelli P; Peebo BB; Xeroudaki M; Koulikovska M; Lagali N
Exp Eye Res; 2014 Aug; 125():118-27. PubMed ID: 24933712
[TBL] [Abstract][Full Text] [Related]
18. Microporous Drug Delivery System for Sustained Anti-VEGF Delivery to the Eye.
Zhou C; Singh A; Qian G; Wolkow N; Dohlman CH; Vavvas DG; Chodosh J; Paschalis EI
Transl Vis Sci Technol; 2020 Jul; 9(8):5. PubMed ID: 32855852
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical aflibercept versus topical bevacizumab for the prevention of corneal neovascularization in a rat model.
Sella R; Gal-Or O; Livny E; Dachbash M; Nisgav Y; Weinberger D; Livnat T; Bahar I
Exp Eye Res; 2016 May; 146():224-232. PubMed ID: 27020759
[TBL] [Abstract][Full Text] [Related]
20. Serine Proteinase Inhibitor SERPINA3K Suppresses Corneal Neovascularization via Inhibiting Wnt Signaling and VEGF.
Zhou T; Chen L; Huang CH; Lin Z; Zong R; Zhu C; Pan F; Ma JX; Liu ZG; Zhou Y
Invest Ophthalmol Vis Sci; 2014 Jul; ():. PubMed ID: 25028361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
